Noa Biran

14PUBLICATIONS
83CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Feb 27, 2026
Salvage Therapy in Multiple Myeloma With Prior T-Cell Engager Exposure: Talquetamab, Elranatamab or Teclistamab in Combination With Pomalidomide.

James Di Palma-Grisi, David Vesole, David Siegel

|Jul 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Ola Landgren, Noa Biran, Elizabeth K O'Donnell

|Apr 15, 2025
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.

Noa Biran, Binod Dhakal, Ruben Niesvizky

|Dec 05, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.

Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller

Pageof 3

Frequent Collaborators

3 joint publications

Doris K Hansen

2 joint publications

Binod Dhakal

2 joint publications

Oren Pasvolsky

2 joint publications

Divaya Bhutani